Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting bgr;2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|9|2|144-150

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.9, Iss.2, 2015-08, pp. : 144-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Claims of Current Inhaled Corticosteroid Patents for Treating Asthma

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 146-150

Bentham Science Publishers

Access to resources Recommend Favorite

Daclizumab: A Potential Asthma Therapy?

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 214-221

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF, Angiopoietin-1 and -2 in Bronchial Asthma: New Molecular Targets in Airway Angiogenesis and Microvascular Remodeling

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 1, 2007-02 ,pp. : 1-8

Bentham Science Publishers

Access to resources Recommend Favorite

Experimental Approaches Towards Allergic Asthma Therapy-Murine Asthma Models

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 1, 2010-01 ,pp. : 37-53

Bentham Science Publishers

Access to resources Recommend Favorite